| Exercise of Warrants | 01-May-2026 | 07:00 | RNS |
| Half-Year Report for Six Months Ended 31 Dec 2025 | 12-Mar-2026 | 07:00 | RNS |
| Half-Year Report for Six Months Ended 31 Dec 2025 | 12-Mar-2026 | 07:00 | RNS |
| Notice of Results and Investor Presentation | 03-Mar-2026 | 07:00 | RNS |
| Restart of Phase 2-enabling toxicology programme | 17-Feb-2026 | 07:00 | RNS |
| Form 8.3 - Oxford Biomedica plc | 23-Jan-2026 | 16:36 | RNS |
| Results of AGM | 09-Dec-2025 | 16:25 | RNS |
| Annual General Meeting Statement | 09-Dec-2025 | 07:00 | RNS |
| Notice of AGM, Annual Report and Accounts | 17-Nov-2025 | 07:00 | RNS |
| Appointment of Joint Corporate Broker | 30-Oct-2025 | 07:00 | RNS |
| Preliminary Results for Year Ended 30 June 2025 | 23-Oct-2025 | 07:00 | RNS |
| Update on toxicology study for SDC-1801 | 10-Oct-2025 | 07:00 | RNS |
| Notice of Results and Investor Presentation | 07-Oct-2025 | 07:00 | RNS |
| Exercise of Warrants | 26-Sep-2025 | 15:12 | RNS |
| Exercise of Warrants | 18-Sep-2025 | 12:59 | RNS |
| Currency | UK Pounds |
| Share Price | 20.25p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 27.50 |
| 52 Week Low | 12.00 |
| Volume | 13,132 |
| Shares Issued | 138.07m |
| Market Cap | £27.96m |
| RiskGrade | 594 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:17 | 239 @ 19.75p |
| 13:52 | 2,000 @ 19.75p |
| 12:41 | 3,000 @ 19.76p |
| 12:28 | 24 @ 20.55p |
| 12:25 | 1,340 @ 19.76p |
You are here: research